New hepatitis b drug shows promise in early human testing
NCT ID NCT03365947
First seen Nov 01, 2025 · Last updated May 05, 2026 · Updated 24 times
Summary
This study tested a new drug called ARO-HBV in healthy volunteers and people with chronic hepatitis B. The main goal was to check if the drug is safe and how the body processes it. A total of 114 people took part, and researchers monitored side effects and drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site 1
Grafton, Auckland, 1010, New Zealand
-
Research Site 2
Papatoetoe, Auckland, 2025, New Zealand
-
Research Site 3
Melbourne, Victoria, 3065, Australia
-
Research Site 4
Clayton, Victoria, 3168, Australia
-
Research Site 5
Camperdown, New South Wales, 2050, Australia
-
Research Site 6
Nedlands, Western Australia, 6009, Australia
-
Research Site 7
Hong Kong, Hong Kong
Conditions
Explore the condition pages connected to this study.